Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-10-24 00:00:00 ET · period of report 2022-10-20 · accession 0000899243-22-034035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-24 | 2022-10-20+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.45 | -398.1K | 24.16M | -2% | -$977.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-20 | S | D | 196,721 | $2.47 | 24,362,512 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-10-21 | S | D | 201,371 | $2.44 | 24,161,141 | D | — | — |